Systemic corticosteroid use to manage uncontrolled asthma and its associated healthcare
burden may account for important health-related adverse effects. We conducted a systematic …

Chronic obstructive pulmonary disease (COPD), a disease that encompasses emphysema,
chronic obstructive bronchitis and small airway obstruction and that is characterised by …

Oral corticosteroids (OCS) are a key part of therapy regimens for a diverse variety of
conditions. Despite their efficacy, they are associated with a wide variety of adverse events …

If ever there was a magic potion that should resolve the symptoms of an affliction, it is the
use of glucocorticoids in asthma. Since their first clinical application, there has been uniform …

Background Although inhaled corticosteroids are effective for the treatment of asthma, it is
uncertain whether their use can prevent death from asthma. Methods We used the …

According to the current clinical practice guidelines for chronic obstructive pulmonary
disease (COPD), the addition of inhaled corticosteroids (ICS) to long-acting β 2 agonist …

Background In clinical trials, the use of inhaled corticosteroids is associated with an
increased risk of pneumonia in people with COPD, but whether the same is true for people …

The widespread use of inhaled corticosteroids (ICS) for the treatment of persistent asthma,
although highly effective, may be associated with both systemic and local side effects …

Inhaled corticosteroids (ICS) are now very widely used in high doses in the management of
COPD patients. In sharp contrast to the situation in asthma, ICS provide little or no benefit in …